| 000 | 01666 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513182910.0 | ||
| 264 | 0 | _c19990609 | |
| 008 | 199906s 0 0 eng d | ||
| 022 | _a0014-4827 | ||
| 024 | 7 |
_a10.1006/excr.1999.4441 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDal Pra, I | |
| 245 | 0 | 0 |
_aChanges in nuclear protein kinase C-delta holoenzyme, its catalytic fragments, and its activity in polyomavirus-transformed pyF111 rat fibroblasts while proliferating and following exposure to apoptogenic topoisomerase-II inhibitors. _h[electronic resource] |
| 260 |
_bExperimental cell research _cMay 1999 |
||
| 300 |
_a147-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCaspases _xphysiology |
| 650 | 0 | 4 | _aCatalysis |
| 650 | 0 | 4 | _aCell Division |
| 650 | 0 | 4 | _aCell Transformation, Viral |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aEtoposide _xpharmacology |
| 650 | 0 | 4 |
_aFibroblasts _xenzymology |
| 650 | 0 | 4 |
_aIsoenzymes _xmetabolism |
| 650 | 0 | 4 |
_aNuclear Envelope _xenzymology |
| 650 | 0 | 4 |
_aPolyomavirus _xphysiology |
| 650 | 0 | 4 |
_aProtein Kinase C _xmetabolism |
| 650 | 0 | 4 | _aProtein Kinase C-delta |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 |
_aTeniposide _xpharmacology |
| 650 | 0 | 4 | _aTopoisomerase II Inhibitors |
| 700 | 1 | _aWhitfield, J F | |
| 700 | 1 | _aChiarini, A | |
| 700 | 1 | _aArmato, U | |
| 773 | 0 |
_tExperimental cell research _gvol. 249 _gno. 1 _gp. 147-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/excr.1999.4441 _zAvailable from publisher's website |
| 999 |
_c10287819 _d10287819 |
||